$CJMB

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously reported, on August 19, 2026, Callan JMB Inc. (the “Company”), together with its wholly owned subsidiary Call

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 26, 2026, Callan Power LLC, a Nevada limited liability company (“ Buyer ”) and a subsidiary of Callan JMB Inc. (the “ Company ”), entered into an Asset Purchase and Sale Agreement (the “ APA ”) with The Pfanenstiel

Callan JMB Inc. (CJMB) will acquire oil and gas assets in the Williston Basin for $12.5M, adding 377 wells and 150 BOE/day production. The deal, expected to close by October 2026, includes $48.1M in proved PV-10 reserves and $82.7M in 3P PV-10 reserves, with an estimated 21.2% unlevered cash return at $75 WTI.

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 19, 2026, Callan JMB Inc., a Nevada corporation (the “ Company ”), together with its wholly owned subsidiary Callan Power LLC, a Nevada limited liability company (“ Buyer ”), entered into an Asset Purchase and Sale

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. On August 18, 2026, Callan JMB Inc., a Nevada corporation (the “ Company ”), entered into a First Amended and Restated Purchase Agreement (the “ Amended Purchase Agreement ”) with a certain investor (the “ Investor ”), which

Callan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.

Callan JMB Inc. (NASDAQ: CJMB) said it has partnered with Alabama State University to support workforce development and applied research at Atlas Complex in Marion, Alabama. The planned 150-acre pharmaceutical and medical logistics campus aims to support U.S. pharmaceutical onshoring and domestic supply chains, targeting more than $430 million in annual revenue at maturity.

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 Settlement, Waiver and Release Agreement This Settlement, Waiver and Release Agreement (“ Agreement ” or “ Settlement Agreement ”) is made and entered into as of June 5, 2026 (“ Effective Date ”) by and between CALLAN JMB Inc., a Nevada C

Dial Gerald purchased 10,000 shares of CALLAN JMB INC. (CJMB) at $0.76 on 2025-12-30.

Callan JMB Inc. has issued a statement regarding a lawsuit filed against it by Eddie Patent Holdings, LLC in the U.S. District Court for the Northern District of Texas. The company, an integrative logistics provider for the healthcare industry, believes the claims are without merit and intends to respond through legal channels. Callan JMB emphasized that the litigation does not affect its operations or strategic partnerships and remains focused on its long-term goals.